Celecoxib may be a viable treatment option for breast cancer patients not treated with chemotherapy.

Harris, Randall E; Schwartzbaum, Judith A

Harris, Randall E; Schwartzbaum, Judith A.

Affiliation

Harris RE; College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Schwartzbaum JA; College of Public Health, The Ohio State University Wexner Medical Center, Columbus, OH, United States.

Front Oncol ; 12: 958308, 2022.

Article in En | MEDLINE | ID: mdl-36267976

Key words

breast cancer; celecoxib; clinical trial; cyclooxygenase; inflammation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: United States